Bridgeway Capital Management’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-1,554
| Closed | -$77K | – | 1500 |
|
|
2015
Q4 | $77K | Sell |
1,554
-74
| -5% | -$3.67K | ﹤0.01% | 1384 |
|
|
2015
Q3 | $291K | Buy |
1,628
+1,250
| +331% | +$223K | 0.01% | 1225 |
|
|
2015
Q2 | $54K | Hold |
378
| – | – | ﹤0.01% | 1468 |
|
|
2015
Q1 | $51K | Hold |
378
| – | – | ﹤0.01% | 1455 |
|
|
2014
Q4 | $68K | Sell |
378
-300
| -44% | -$54K | ﹤0.01% | 1412 |
|
|
2014
Q3 | $163K | Buy |
678
+18
| +3% | +$4.33K | ﹤0.01% | 1363 |
|
|
2014
Q2 | $289K | Hold |
660
| – | – | 0.01% | 1260 |
|
|
2014
Q1 | $302K | Hold |
660
| – | – | 0.01% | 1242 |
|
|
2013
Q4 | $317K | Buy |
660
+250
| +61% | +$120K | 0.01% | 1210 |
|
|
2013
Q3 | $198K | Hold |
410
| – | – | 0.01% | 1318 |
|
|
2013
Q2 | $193K | Buy |
+410
| New | +$193K | 0.01% | 1277 |
|